OneMedNet Revolutionizes Data Curation with AI, Boosting Efficiency up to 5X
OneMedNet (Nasdaq: ONMD) has successfully integrated proprietary AI technology into its data curation process, revolutionizing the way healthcare data is managed. This innovation has significantly reduced operational costs and increased efficiency, allowing the company to:
- Process vast amounts of clinical data in minutes instead of hours
- Deliver longitudinal clinical data and images up to 5 times faster
- Respond to sales inquiries much quicker
The AI-driven de-identification process enhances data privacy while maintaining high-quality, regulatory-grade datasets. This advancement positions OneMedNet as a leader in Real World Data (RWD) curation, setting new standards for accuracy and speed in the healthcare data industry.
OneMedNet (Nasdaq: ONMD) ha integrato con successo una tecnologia AI proprietaria nel suo processo di curatela dei dati, rivoluzionando il modo in cui vengono gestiti i dati sanitari. Questa innovazione ha significativamente ridotto i costi operativi e aumentato l'efficienza, permettendo all'azienda di:
- Elaborare enormi quantità di dati clinici in minuti anziché in ore
- Fornire dati clinici longitudinali e immagini fino a 5 volte più veloci
- Rispondere alle richieste di vendita in modo molto più rapido
Il processo di de-identificazione guidato dall'intelligenza artificiale migliora la privacy dei dati mantenendo set di dati di alta qualità e conformi alle normative. Questo progresso posiziona OneMedNet come leader nella curatela dei Dati del Mondo Reale (RWD), stabilendo nuovi standard di accuratezza e velocità nell'industria dei dati sanitari.
OneMedNet (Nasdaq: ONMD) ha integrado con éxito una tecnología AI propietaria en su proceso de curación de datos, revolucionando la manera en que se gestionan los datos de salud. Esta innovación ha reducido significativamente los costos operacionales y ha aumentado la eficiencia, permitiendo a la empresa:
- Procesar grandes volúmenes de datos clínicos en minutos en lugar de horas
- Entregar datos clínicos longitudinales e imágenes hasta 5 veces más rápido
- Responder a las consultas de ventas de manera mucho más rápida
El proceso de desidentificación impulsado por AI mejora la privacidad de los datos mientras mantiene conjuntos de datos de alta calidad y conformes a la normativa. Este avance posiciona a OneMedNet como líder en la curación de Datos del Mundo Real (RWD), estableciendo nuevos estándares de precisión y velocidad en la industria de datos de salud.
OneMedNet (Nasdaq: ONMD)는 데이터 큐레이션 프로세스에 독점 AI 기술을 성공적으로 통합하여 의료 데이터 관리 방식을 혁신했습니다. 이 혁신은 운영 비용을 크게 줄이고 효율성을 높였으며, 회사는 다음을 수행할 수 있습니다:
- 수 시간 대신 몇 분 안에 방대한 임상 데이터를 처리
- 5배 더 빠른 속도로 장기적인 임상 데이터 및 이미지를 전달
- 판매 문의에 훨씬 더 빠르게 응답
AI 기반의 비개인화 프로세스는 데이터의 개인 정보 보호를 강화하면서 고품질의 규제 등급 데이터셋을 유지합니다. 이 발전은 OneMedNet을 실제 데이터(RWD) 큐레이션 분야의 선두주자로 자리매김하게 하여, 의료 데이터 산업에서 정확성과 속도의 새로운 기준을 설정합니다.
OneMedNet (Nasdaq: ONMD) a intégré avec succès une technologie IA propriétaire dans son processus de curation des données, révolutionnant ainsi la gestion des données de santé. Cette innovation a considérablement réduit les coûts opérationnels et augmenté l'efficacité, permettant à l'entreprise de :
- Traiter d'énormes quantités de données cliniques en quelques minutes au lieu de plusieurs heures
- Fournir des données cliniques longitudinales et des images jusqu'à 5 fois plus rapidement
- Répondre aux demandes de vente beaucoup plus rapidement
Le processus de désidentification piloté par l'IA améliore la confidentialité des données tout en maintenant des ensembles de données de haute qualité conformes à la réglementation. Ce progrès positionne OneMedNet comme un leader dans la curation des Données du Monde Réel (RWD), établissant de nouveaux standards en matière de précision et de rapidité dans l'industrie des données de santé.
OneMedNet (Nasdaq: ONMD) hat erfolgreich eine proprietäre KI-Technologie in seinen Datenkurationprozess integriert und revolutioniert damit die Verwaltung von Gesundheitsdaten. Diese Innovation hat die Betriebskosten erheblich gesenkt und die Effizienz gesteigert, sodass das Unternehmen:
- Gigantische Mengen klinischer Daten in Minuten statt in Stunden verarbeiten kann
- Langfristige klinische Daten und Bilder bis zu 5 Mal schneller bereitstellen kann
- Verkaufsanfragen viel schneller beantworten kann
Der von KI gesteuerte Prozess der Entidentifizierung verbessert den Datenschutz, während hochwertige, regelkonforme Datensätze beibehalten werden. Diese Weiterentwicklung positioniert OneMedNet als führend in der Kuration von Real World Data (RWD) und setzt neue Standards für Genauigkeit und Geschwindigkeit in der Gesundheitsdatenbranche.
- Integration of proprietary AI technology into data curation process
- Significant reduction in operational costs
- Up to 5x faster delivery of longitudinal clinical data and images
- Improved customer service and business performance through faster sales inquiry responses
- Enhanced data privacy while maintaining high-quality, regulatory-grade datasets
- None.
OneMedNet's integration of AI into its data curation process marks a significant leap in healthcare data management. The 5X increase in processing speed is a game-changer, potentially accelerating drug development and clinical research timelines. This efficiency boost could lead to cost savings and faster time-to-market for new treatments.
The AI-driven de-identification process addresses a critical challenge in healthcare data: maintaining patient privacy while maximizing data utility. This could open doors to more comprehensive and diverse datasets, enhancing the quality of Real World Data available for research. However, it's important to monitor the AI's accuracy and ensure it meets stringent regulatory standards for data privacy.
OneMedNet's AI integration presents a compelling value proposition that could significantly impact its financial performance. The reduced operational costs and increased efficiency should lead to improved profit margins. Faster data delivery could also enhance customer satisfaction, potentially driving sales growth and market share expansion in the competitive RWD market.
Investors should watch for metrics such as customer acquisition rates, contract values and profit margins in upcoming financial reports to gauge the real-world impact of this technological advancement. While the innovation is promising, it's important to assess how it translates into tangible financial benefits and competitive advantage in the long term.
The accelerated data curation process by OneMedNet could revolutionize medical research workflows. Faster access to high-quality, de-identified datasets means researchers can initiate studies more quickly and potentially increase the volume of research conducted. This could lead to more rapid advancements in understanding diseases, drug efficacy and treatment outcomes.
However, it's important to ensure that the AI-driven process maintains the integrity and completeness of the data. Researchers will need assurances that the rapid curation doesn't compromise data quality or introduce biases. If OneMedNet can consistently deliver on both speed and quality, it could become an indispensable tool in advancing evidence-based medicine and personalized healthcare.
MINNEAPOLIS, Aug. 09, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data (RWD), has successfully integrated its proprietary AI technology into its data curation process, ensuring rapid and precise de-identification of patient data. This innovation, coupled with other changes undertaken by the Company, has significantly reduced OneMedNet’s operational costs, enabling the company to process vast amounts of clinical data in minutes rather than hours. Additionally, OneMedNet can now deliver longitudinal clinical data and images to Life Science organizations up to five times faster than before, as measured from the end-to-end data curation process, significantly expediting delivery.
"The integration of AI into our de-identification processes not only enhances our data privacy but also significantly boosts our operational efficiency, allowing us to quickly provide high-quality, de-identified datasets to our customers," stated Aaron Green, CEO & President of OneMedNet. "Furthermore, AI has enabled us to respond to sales inquiries much faster, improving our customer service and overall business performance."
OneMedNet’s AI-driven de-identification process is a critical component of the company’s iRWD™ platform, which is already recognized for its ability to manage diverse clinical data, including electronic health records, laboratory results, and medical imaging. With the added layer of AI, OneMedNet is setting a new standard for how healthcare data is curated, offering unparalleled accuracy and speed in delivering regulatory-grade, de-identified datasets to its customers.
About OneMedNet Corporation
OneMedNet provides innovative solutions that unlock the significant value contained within the Real-World Data (“RWD”) repositories of over 1,400 healthcare system and provider sites that currently comprise its iRWD™ network. OneMedNet’s proprietary iRWD™ platform provides secure, comprehensive management of diverse clinical data types, including electronic health records, laboratory results, and uniquely, medical imaging. Employing its robust iRWD™ platform, the Company securely de-identifies, searches, and curates the clinical data, bringing a wealth of internal and third-party research opportunities to its drug, medical device and imaging/diagnostic AI development customers.
OneMedNet’s platform is designed to meet the clinical requirements necessary across various domains, including but not limited to rare diseases, oncology, and cardiology. The Company is committed to delivering precise and robust research support services that span the entire continuum of care. This commitment is a cornerstone of OneMedNet’s strategy to enhance patient outcomes and help pave the next wave of healthcare innovation. For more information, please visit www.onemednet.com.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.
OneMedNet Contacts:
Stephen Kilmer, Investor Relations
Phone: 647.872.4849
Email: stephen.kilmer@onemednet.com
Michael Wong, Director of Marketing
Phone: 800.918.7189
Email: michael.wong@onemednet.com
SOURCE: ONEMEDNET CORPORATION
FAQ
How has OneMedNet's AI integration improved its data curation process?
What is the impact of AI integration on OneMedNet's operational costs?
How does OneMedNet's AI-driven de-identification process affect data privacy?
What is OneMedNet's stock symbol?
